Johnson & Johnson (JNJ) | Stock Overview & Key Data

Johnson & Johnson | Healthcare

$155.26

-0.76%

| Johnson & Johnson Stock Comparison:

Johnson & Johnson vs Eli Lilly and Johnson & Johnson vs AbbVie Johnson & Johnson vs Merck & Co Johnson & Johnson vs Amgen Johnson & Johnson vs Gilead Sciences Johnson & Johnson vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Johnson & Johnson Performance Comparison

Loading chart data...

Johnson & Johnson

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $154.73 High: $156.60

on June 11, 2025

52 Week Range

Low: $140.68 High: $169.99

on January 10, 2025

on March 4, 2025

All-Time High: $186.69 on April 25, 2022

Key Statistics

Market Cap i $376.4B

EPS i 8.99

P/E Ratio (TTM) i 17.40

Forward P/E i 14.76

P/B Ratio i 4.82

PEG Ratio i 14.76

Div. Yield i 3.17%

ROE i 29.45%

Beta i 0.410

Debt to Equity i 66.90

Financial Highlights

Profitability

Gross Margin i 66.40%

Operating Margin i 29.41%

Profit Margin i 24.42%

Returns and Earnings

Return on Assets (TTM) i 7.77%

Return on Equity (TTM) i 29.45%

EBITDA i $31.9B

Net Income (TTM) i $21.8B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $4.96

Estimated Dividend Yield i 3.17%

5 Year Average Dividend Yield i 2.77%

Last 12-Month Dividend Yield i 3.17%

Last 12-Month Dividend i $4.96

% of Earnings Paid as Dividends i 55.17%

Dividend Date i June 10, 2025

Ex-Dividend Date i May 27, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Johnson & Johnson JNJ	376.43B Mega-cap	1.32%	0.72%	-6.40%	5.87%	7.80%	6.67%	-8.39%	7.94%
Eli Lilly and LLY	725.05B Mega-cap	5.59%	7.02%	-1.87%	1.58%	3.93%	-7.92%	178.07%	405.76%
AbbVie ABBV	338.27B Mega-cap	2.21%	0.74%	-10.35%	9.81%	6.71%	13.58%	38.48%	98.00%
Merck & Co MRK	204.27B Mega-cap	2.62%	-0.14%	-15.21%	-19.48%	-19.01%	-37.97%	-5.08%	8.06%
Amgen AMGN	156.11B Large-cap	1.70%	6.24%	-8.46%	6.76%	12.58%	-2.26%	24.34%	22.27%
Gilead Sciences GILD	136.94B Large-cap	0.27%	5.29%	-4.47%	18.33%	18.97%	68.04%	86.79%	41.13%

Ownership & Short Interest

Insider Ownership i 0.06%

Institutional Ownership i 74.04%

Shares Short i 23M

Short Ratio i 2.83

Short % of Shares Outstanding i 0.95%

Average 10-Day Volume i 7M

Average 90-Day Volume i 8M

Johnson & Johnson Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Johnson & Johnson would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is JNJ's 52-week high and low?

In the last 52 weeks, Johnson & Johnson reached a high of $169.99 (on March 4, 2025) and a low of $140.68 (on January 10, 2025).

What is the market cap and P/E ratio for JNJ?

Curious about Johnson & Johnson's size and valuation? Its market capitalization stands at 376.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.40, and the forward P/E (looking ahead) is 14.76.

Does JNJ pay dividends? If so, what's the yield?

Yes, Johnson & Johnson is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.17%, and the company is expected to pay out $4.96 per share over the coming year.

Who are Johnson & Johnson's main competitors or similar companies to consider before investing?

When looking at Johnson & Johnson, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Eli Lilly and LLY	725.05B	Healthcare	Drug Manufacturers - General	-7.92%	178.07%
AbbVie ABBV	338.27B	Healthcare	Drug Manufacturers - General	13.58%	38.48%
Merck & Co MRK	204.27B	Healthcare	Drug Manufacturers - General	-37.97%	-5.08%
Amgen AMGN	156.11B	Healthcare	Drug Manufacturers - General	-2.26%	24.34%
Gilead Sciences GILD	136.94B	Healthcare	Drug Manufacturers - General	68.04%	86.79%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Johnson & Johnson? (e.g., ROE, Debt/Equity)

To get a sense of Johnson & Johnson's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 29.45%, the Debt to Equity ratio from the most recent quarter is 66.90, and its Gross Profit Margin stands at 66.40%.

What is the recent revenue and earnings growth for JNJ?

Looking at Johnson & Johnson's growth, its revenue over the trailing twelve months (TTM) was $89B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.40%, and quarterly earnings saw a YoY growth of 237.90%.

How much of JNJ stock is held by insiders and institutions?

Wondering who owns Johnson & Johnson stock? Company insiders (like executives and directors) hold about 0.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 74.04%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.